While glucagon does raise blood sugar, the dual incretin activity of GLP-1 and GIP offset these hyperglycemic effects while retaining the energy expenditure benefits
Here is what the clinical evidence consistently shows: Significant, sustained weight loss The STEP clinical trials for semaglutide showed average weight loss of 14.9% of body weight over 68 weeks more than double the typical result from traditional dieting programs
Lancet (2019) 394(10192):3950
B12 injections, metabolic testing, and hormone evaluation
Ferroptosis, an iron-dependent form of programmed cell death first identified by Dixon et al., is characterized by excessive intracellular iron accumulation, lipid peroxidation and distinct biochemical and morphological features (Liu et al., 2021)
At AgeRejuvenation, BPC-157 is offered under provider supervision as part of a personalized peptide therapy plan across our Florida clinics serving Tampa Bay and Orlando